LIV Process presented its first-ever Invisible Hero Award to the Environmental Services team in recognition of their role in preventing the spread of C. diff.

In a featured interview with Pharmacy Times, LIV Process highlighted its mission to transform infection prevention by making invisible Clostridioides

LIV Process is included in the article from bozjournals.com that spotlights 10 Philadelphia-area startups to watch in 2026, emphasizing companies

Thank you to Christie Ileto and team at 6abc WPVI-TV Philadelphia for featuring LIV Process in honor of C. diff

The VA has contracted to use our product, a fluorescence-based system that makes C. difficile contamination on hospital surfaces visible

Philadelphia-based biotech LIV Process is developing a new technology that helps hospitals visualize dangerous microbes like Clostridioides difficile (C. diff)

Philadelphia-based biotech company LIV Process unveiled a new “microbial visualization” technology at IDWeek 2025 that lets healthcare workers see pathogens

Philadelphia-based biotech LIV Process unveiled a patented “microbial visualization” technology at IDWeek 2025 that makes dangerous pathogens like Clostridioides difficile

LIV Process CEO and Founder, Michael McIntyre was recently featured on FOX29 News, sharing insights on the first and only product in the

Here’s a quick summary of the “Shining a Light on C diff Could Save Millions of Lives” podcast episode from